• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无缝线小梁切除术联合多孔胶原(Ologen)在青光眼患者治疗中的疗效和安全性。

Efficacy and Safety of Sutureless Trabeculectomy with Using Porous Collagen (Ologen) in Management of Glaucoma Patients.

机构信息

Department of Ophthalmology, Southampton University Hospital NHS Foundation Trust, Southampton, UK.

Department of Ophthalmology, Faculty of Medicine, Aswan University, Aswan, Egypt.

出版信息

Korean J Ophthalmol. 2021 Aug;35(4):304-310. doi: 10.3341/kjo.2021.0044. Epub 2021 Jun 21.

DOI:10.3341/kjo.2021.0044
PMID:34162185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8357608/
Abstract

PURPOSE

This study aims to investigate the safety, efficacy and feasibility of sutureless trabeculectomy using a porous collagen matrix that contains a connected porous structure (Ologen) in the control of intraocular pressure (IOP) in glaucoma patients .

METHODS

The study includes 25 eyes from 24 patients that met the inclusion criteria. All eyes underwent trabeculectomy with the Ologen implant that provides a space with a dynamic and physiological aqueous reservoir system. The operation was considered successful if IOP is <15 mmHg without need of IOP-lowering drops at 18 months of follow-up.

RESULTS

The target IOP was achieved in 21 out of the 25 eyes (84%), the remaining four eyes all had an IOP of 16 mmHg at 18 months. Short-term complications consisted of seven cases of bleb leakage treated with bandage contact lens and one case of mild choroidal effusion which resolved after observation alone.

CONCLUSIONS

We can conclude that this technique can provide safety, effectiveness and short learning curve for ophthalmology trainees with lower incidence of perioperative and postoperative complications. Further studies may be required to prove stability and long-term efficacy in management of glaucoma patients.

摘要

目的

本研究旨在探讨使用含有连通多孔结构的多孔胶原基质(Ologen)进行无缝小梁切除术的安全性、有效性和可行性,以控制青光眼患者的眼内压(IOP)。

方法

本研究纳入了符合纳入标准的 24 例患者的 25 只眼。所有眼均行 Ologen 植入物小梁切除术,该植入物提供了一个具有动态和生理房水储液系统的空间。如果在 18 个月的随访中,IOP<15mmHg 且无需使用降眼压滴注,则认为手术成功。

结果

25 只眼中有 21 只(84%)达到了目标眼压,其余 4 只眼在 18 个月时的眼压均为 16mmHg。短期并发症包括 7 例眼泡漏,用绷带接触镜治疗,1 例轻度脉络膜积液,经单纯观察后缓解。

结论

我们可以得出结论,这种技术可以为眼科培训生提供安全性、有效性和较短的学习曲线,同时降低围手术期和术后并发症的发生率。可能需要进一步的研究来证明在青光眼患者管理中的稳定性和长期疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/d42b205c9b67/kjo-2021-0044f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/191d96f73554/kjo-2021-0044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/d8de08478e7f/kjo-2021-0044f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/d42b205c9b67/kjo-2021-0044f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/191d96f73554/kjo-2021-0044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/d8de08478e7f/kjo-2021-0044f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ea/8357608/d42b205c9b67/kjo-2021-0044f3.jpg

相似文献

1
Efficacy and Safety of Sutureless Trabeculectomy with Using Porous Collagen (Ologen) in Management of Glaucoma Patients.无缝线小梁切除术联合多孔胶原(Ologen)在青光眼患者治疗中的疗效和安全性。
Korean J Ophthalmol. 2021 Aug;35(4):304-310. doi: 10.3341/kjo.2021.0044. Epub 2021 Jun 21.
2
Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.前瞻性随机对照试验比较丝裂霉素 C 联合 Ologen 植入物与单独丝裂霉素 C 作为小梁切除术辅助剂的效果。
Ophthalmol Glaucoma. 2018 Sep-Oct;1(2):88-98. doi: 10.1016/j.ogla.2018.07.003. Epub 2018 Jul 30.
3
Comparison of the Outcomes of Trabeculectomy with 5-Fluorouracil versus Ologen Implant in Primary Open-Angle Glaucoma.原发性开角型青光眼小梁切除术联合5-氟尿嘧啶与Ologen植入物的疗效比较
Ophthalmic Res. 2017;58(2):94-98. doi: 10.1159/000471883. Epub 2017 May 4.
4
Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.巩膜隧道切开术联合胶原基质植入物(Ologen)和低浓度丝裂霉素 C 行小梁切除术和前房内小梁切除术的疗效:2 年随访。
J Glaucoma. 2018 Jan;27(1):50-54. doi: 10.1097/IJG.0000000000000818.
5
Safety and efficacy of collagen matrix implantation in infantile glaucoma.胶原蛋白基质植入术治疗婴幼儿青光眼的安全性和有效性
Eur J Ophthalmol. 2017 May 11;27(3):289-294. doi: 10.5301/ejo.5000859. Epub 2016 Sep 7.
6
Trabeculectomy Combined With Collagen Matrix Implant (Ologen).小梁切除术联合胶原基质植入物(Ologen)
J Glaucoma. 2017 Jan;26(1):54-58. doi: 10.1097/IJG.0000000000000551.
7
Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.在 Ex-PRESS 微型青光眼装置小梁切除术中使用胶原基质植入物 (Ologen) 与丝裂霉素 C 作为伤口愈合调节剂:一项 12 个月的回顾性研究。
J Glaucoma. 2014 Dec;23(9):649-52. doi: 10.1097/IJG.0000000000000018.
8
Long-term outcomes of trabeculectomy with ologen implant versus combined viscotrabeculotomy-synechiolysis in uncontrolled uveitic glaucoma.兔眼滤过术后巩膜瓣下胶原植入与联合黏连松解术治疗难治性葡萄膜炎性青光眼的长期疗效比较
Int Ophthalmol. 2022 Feb;42(2):411-421. doi: 10.1007/s10792-021-02057-9. Epub 2021 Oct 5.
9
[Long-Term Results after Trabeculectomy Combined with Mitomycin C and Ologen Implant].小梁切除术联合丝裂霉素C和Ologen植入物后的长期结果
Klin Monbl Augenheilkd. 2019 Sep;236(9):1107-1114. doi: 10.1055/s-0044-101461. Epub 2018 Mar 28.
10
Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.OloGen与丝裂霉素C在小梁切除术中治疗硅油性青光眼的比较
Klin Monbl Augenheilkd. 2022 Sep;239(9):1147-1154. doi: 10.1055/a-1500-8230. Epub 2021 Jul 1.

本文引用的文献

1
Biodegradable 3D-Porous Collagen Matrix (Ologen) Compared with Mitomycin C for Treatment of Primary Open-Angle Glaucoma: Results at 5 Years.可生物降解的三维多孔胶原基质(Ologen)与丝裂霉素C治疗原发性开角型青光眼的比较:5年结果
J Ophthalmol. 2015;2015:637537. doi: 10.1155/2015/637537. Epub 2015 May 19.
2
Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy.丝裂霉素C辅助小梁切除术后角膜内皮细胞丢失
J Glaucoma. 2008 Dec;17(8):654-7. doi: 10.1097/IJG.0b013e3181659e56.
3
The surgical outcome of primary trabeculectomy with mitomycin C and A fornix-based conjunctival flap technique in Thailand.
泰国采用丝裂霉素C及A形穹窿部结膜瓣技术进行原发性小梁切除术的手术效果。
J Med Assoc Thai. 2008 Oct;91(10):1551-7.
4
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
5
Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure.在人工晶状体植入的开角型青光眼患者中使用丝裂霉素C进行小梁切除术:手术效果及失败的危险因素
Am J Ophthalmol. 2006 Apr;141(4):652-9. doi: 10.1016/j.ajo.2005.11.039.
6
Does the site of filtration influence the medium to long term intraocular pressure control following microtrabeculectomy in low risk eyes?在低风险眼行微小梁切除术后,滤过部位是否会影响中远期眼压控制?
Br J Ophthalmol. 2004 Aug;88(8):1008-11. doi: 10.1136/bjo.2003.028811.
7
Antifibrotics and wound healing in glaucoma surgery.青光眼手术中的抗纤维化与伤口愈合
Surv Ophthalmol. 2003 May-Jun;48(3):314-46. doi: 10.1016/s0039-6257(03)00038-9.
8
Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up.丝裂霉素C在原发性小梁切除术中的疗效与安全性:五年随访
Ophthalmology. 2002 Jul;109(7):1336-41; discussion 1341-2. doi: 10.1016/s0161-6420(02)01069-2.
9
Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.协作性青光眼初始治疗研究中比较随机接受药物或手术初始治疗的中期临床结果。
Ophthalmology. 2001 Nov;108(11):1943-53. doi: 10.1016/s0161-6420(01)00873-9.
10
The long-term outcome of glaucoma filtration surgery.青光眼滤过手术的长期疗效。
Am J Ophthalmol. 2001 Jul;132(1):27-35. doi: 10.1016/s0002-9394(01)00923-0.